Drug archive
Verteporfin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Macular degeneration therapy adjunct
- Photosensitizer
- Photodynamic therapy
Description
Verteporfin (ver-te-POR-fin) is used together with a special laser light, to treat abnormal blood vessel formation in a part of the eye which, if left untreated, can lead to a loss of eyesight.
Verteporfin may also be used for the following problems:
- Pathologic myopia (changes in the eyeball causing vision problems);
- Ocular histoplasmosis (damage to the eye from a fungus found in the soil)
This medicine is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage forms:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Visudyne
In Canada -
- Visudyne
Another commonly used name is benzoporphyrin derivative .